Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
If your prescription is written for type 2 diabetes: Ozempic, Mounjaro, Victoza, and Rybelsus are covered with prior authorization Prior authorization requires documentation of A1C above 7% (or above 8% for some managed care plans), trial of metformin, and contraindication screening Weight loss is considered a beneficial side effect, not the primary indication Monthly copay: $0 If your prescription is written for chronic weight management: Wegovy, Zepbound, and Saxenda are covered with prior authorization Prior authorization requires BMI criteria, comorbidity documentation (if BMI 27-29.9), step therapy completion, and contraindication screening Diabetes is a qualifying comorbidity, but the prescription must be written for obesity, not diabetes Monthly copay: $0 If your prescription is written off-label (diabetes medication prescribed for weight loss in a patient without diabetes): Denied automatically No appeal pathway unless the provider can document an FDA-approved use that the pharmacy benefit manager's system didn't recognize The diagnosis on the prescription determines the coverage pathway
Features: Gauge : 25 to 29 Length : 1/2 inch to 1 inch Purpose : Administration into the fatty tissue just below the skin, ideal for shallow injections SubQ needles are ideal if you want a slower absorption rate
Preliminary research, including a small randomised controlled trial published in Obesity (Robert et al., 2023), examined liraglutide in adults with binge eating disorder and obesity
Take our 2-minute eligibility quiz and we'll let you know on the spot
